Advanced Delivery and Therapeutic Applications of RNAi by Kun Cheng, Ram I. Mahato

Posted by

By Kun Cheng, Ram I. Mahato

RNA interference (RNAi) is a method in residing cells wherein small double stranded RNA interferes with the expression of particular genes with complementary nucleotide series. Like many nucleic acid-based remedies, RNAi has nice capability in treating quite a few life-threatening ailments. besides the fact that, the negative balance and mobile uptake of RNAi molecules stay significant boundaries to their effective supply that is paramount to a profitable treatment. This publication offers a finished creation to RNAi supply, then is going directly to speak about diversified supply suggestions, and concludes with present purposes in a number of ailments. It covers:

  • Mechanisms, limitations, and research of RNAi Delivery
  • Nonclinical defense checks and medical Pharmacokinetics: A Regulatory Perspective
  • Bioconjugation of siRNA for website Specifi c Delivery
  • Nanoscale supply platforms for RNAi
  • Environmentally-Responsive supply platforms for RNAi
  • Light-sensitive RNAi
  • Viral-Mediated supply of shRNA and miRNA
  • RNAi functions in melanoma remedy, Liver ailments, Hepatitis B, and Ocular Disease
  • miRNA as healing brokers and targets

Advanced supply and healing purposes of RNAi combines the basic facets of constructing RNAi therapeutics from bench to hospital, and is precious for researchers engaged on RNAi, drug discovery and supply, biomedical engineering, biomaterials, molecular biology, and biotechnology.

Chapter 1 Mechanisms and obstacles to RNAi supply (pages 3–17): Jiehua Zhou and John J. Rossi
Chapter 2 research of siRNA supply utilizing numerous Methodologies (pages 19–44): Yi Pei
Chapter three demanding situations and possibilities in Bringing RNAi applied sciences from Bench to mattress (pages 45–62): Sandesh Subramanya and Lance Ford
Chapter four Nonclinical protection tests and medical Pharmacokinetics for Oligonucleotide Therapeutics: A Regulatory point of view (pages 63–81): Shwu?Luan Lee, Paul Brown, Jian Wang and Robert T. Dorsam
Chapter five function of Promoters and Micro RNA spine for effective Gene Silencing (pages 83–108): Feng Li and Ram I. Mahato
Chapter 6 Bioconjugation of siRNA for Site?specific supply (pages 111–136): Bin Qin, Wei Jin and Kun Cheng
Chapter 7 Multifunctional RNAi supply platforms (pages 137–161): China Malakondaiah Kummitha, Anthony S. Malamas and Zheng?Rong Lu
Chapter eight Dendrimers in RNAi supply (pages 163–185): Jose Luis Jimenez Fuentes, Paula Ortega, Sara Ferrando?Martinez, Rafael Gomez, Manuel Leal, Javier de los angeles Mata and M?Angeles Munoz? Fernandez
Chapter nine improvement of Pharmaceutically tailored Mesoporous Silica Nanoparticles for siRNA supply (pages 187–205): Wilson X. Mai, Tian Xia and Huan Meng
Chapter 10 Environmentally?Responsive Nanogels for siRNA supply (pages 207–224): Atsushi Tamura and Yukio Nagasaki
Chapter eleven Viral?Mediated supply of shRNA and miRNA (pages 225–254): Fredric P. Manfredsson
Chapter 12 The keep watch over of RNA Interference with gentle (pages 255–268): Simon H. Friedman
Chapter thirteen RNAi in melanoma remedy (pages 271–307): Cristian Rodriguez?Aguayo, Arturo Chavez?Reyes, Gabriel Lopez?Berestein and Anil okay. Sood
Chapter 18 Adenovirus?mediated shRNA supply to melanoma (pages 309–326): Chae?Ok Yun
Chapter 15 RNAi in Liver ailments (pages 327–366): Jiang Li, Jianqin Lu, Yifei Zhang, Mohammed Ghazwani, Peng Zhang, Xiang Gao and track Li
Chapter sixteen methods to providing RNAi Therapeutics that focus on Hepatitis B Virus (pages 367–389): Carol Crowther, Mohube Betty Mowa, Abdullah Ely and Patrick Arbuthnot
Chapter 17 RNAi in respiration illnesses (pages 391–416): Ciara Kelly, Awadh B. Yadav, Paul J. McKiernan, Catherine M. Greene and Sally?Ann Cryan
Chapter 18 RNAi in Ocular illnesses (pages 417–437): Andrey Turchinovich, Georg Zoidl and Rolf Dermietzel
Chapter 19 micro RNAs as healing brokers and ambitions (pages 439–482): D.S. Karolina and ok. Jeyaseelan
Chapter 20 supply of Micro RNA Sponges for Interrogation of Micro RNA functionality In Vitro and In Vivo (pages 483–504): Jiakai Lin and Shu Wang

Show description

Read Online or Download Advanced Delivery and Therapeutic Applications of RNAi PDF

Best organic books

Chemistry of Heterocyclic Compounds: Thiophene and its Derivatives, Part One, Volume 44

Content material: bankruptcy I guidance of Thiophenes through Ring? Closure Reactions and from different Ring structures (pages 1–214): Salo GronowitzChapter II Theoretical Calculations on Thiophenes (pages 215–260): Anita Henriksson? EnfloChapter III certainly Occuring Thiophenes (pages 261–324): F. Bohlmann and C. ZderoChapter IV Thiophenes taking place in Petroleum, Shale Oil, and Coals (pages 325–352): G.

Annual Reports in Organic Synthesis–1995

This convenient reference device is an equipped annual overview of synthetically worthwhile details. It abstracts artificial reactions from the key chemistry journals of the prior yr and contains reactions and techniques thatare new and fairly normal. The reactions are offered in a handy pictorial layout designed for quick visible retrieval of knowledge.

Extra resources for Advanced Delivery and Therapeutic Applications of RNAi

Sample text

2007) Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proceedings of the National Academy of Sciences of the United States of America, 104, 5715–5721. 78. Pal, A. et al. (2005) Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer. International Journal of Oncology, 26, 1087–1091. 79. M.

Third, potent siRNAs against a given target may be readily identified by selections in silico and in vitro without extensive screenings. Despite all the good traits, there are several inherent weaknesses associated with siRNA: (i) with its 14 kDa size and net negative charge, siRNA does not easily cross the cell membrane to find its target; (ii) siRNA is vulnerable to endogenous RNases and (iii) siRNA may cause off-target effects, which could be sequence dependent or sequence independent. In order to circumvent these limitations, two major strategies have been implemented in parallel.

After the RACE procedure, specific cleavage product is revealed by gel electrophoresis and/or sequencing. com, accessed 12 January 2013). The delivered siRNA may cause off-target effects at mRNA level, which can be analyzed by the microarray approach. One type of off-target effect involves downregulation of bystander mRNAs containing imperfect complementarities to the strand in RISC [40]. Hence the signature of the off-target effects from each strand may serve as indirect readout for the delivery of the respective strand.

Download PDF sample

Rated 4.98 of 5 – based on 18 votes